- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0014196

About Inlife Pharma Private Limited
Data last updated:
Inlife Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 September 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG1999PTC032540. Its GSTIN is 36AAACO4086H1ZD (Telangana). The company holds 10 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15.68 Lakh. It was formerly known as Orbit It Consulting Private Limited. It is led by directors including Anil Kanodia (Managing Director) and Mukta Madanmohan Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 – 6 – 365/110A Liberty Plaza Himayatnagar, Hyderabad, Telangana, India – 500029.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.84 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹39.31 Lakh (net margin 2.5%) and EBITDA of ₹1.19 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 20% over five years.
The company is associated with 1 brand: Inlife Healthcare. As per MCA filings, the company has open charges of ₹1.87 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Inlife Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0014196). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website inlifehealthcare.com.
Company details
CIN history
Inlife Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG1999PTC032540, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG1999PTC032540 | Current |
| U24100AP1999PTC032540 | Previous |
| U72200AP1999PTC032540 | Previous |
Recognitions & Rankings of Inlife Pharma
Contact details
Inlife Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is inlifehealthcare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3 – 6 – 365/110A Liberty Plaza Himayatnagar, Hyderabad, Telangana, India – 500029
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Inlife Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Inlife Pharma operates one associated brand: Inlife Healthcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Health supplements, vitamins, and Ayurvedic products are offered by Inlife in India. | inlifehealthcare.com |
Business activity
The main business activity of Inlife Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Inlife Pharma Private Limited, buy the company report.
Financials of Inlife Pharma Private Limited
FY 2025 filings availableInlife Pharma Private Limited reported revenue of ₹15.84 Cr (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 25% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inlife Pharma Private Limited, buy the company report.
Board of directors of Inlife Pharma Private Limited
Inlife Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukta Madanmohan Agarwal | Director | 10 Dec 2018 | 7 Years 11 Months | Current |
| Prateek Agarwal | Director | 15 Apr 2013 | 13 Years 7 Months | Current |
| Chetan Agarwal | Director | 15 Apr 2013 | 13 Years 7 Months | Current |
| Anil Kanodia Also directs: Orbit Technology Research Private Limited | Managing Director | 01 Feb 2001 | 25 Years 9 Months | Current |
Auditor
Inlife Pharma Private Limited is audited by TVSRAO&ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TVSRAO&ASSOCIATES | FY 2022 | 06762S |
Shareholding
The shareholding of Inlife Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Inlife Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 May 2025 | 101106447 | Hdfc Bank Limited | ₹20.64 Lakh | Open | |
| 10 Mar 2023 | 100720139 | Hdfc Bank Limited | ₹19.27 Lakh | Open | |
| 03 Jul 2021 | 100460754 | Hdfc Bank Limited | ₹16.84 Lakh | Open | |
| 16 Apr 2019 | 100255968 | Hdfc Bank Limited | ₹1.3 Cr | Open |
To see the full charge records of Inlife Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Inlife Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nalgonda, Telangana | Court case (MVOP) | Filed against the company | Pending |
To see the full case history of Inlife Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inlife Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inlife Pharma has 10 GST registrations: 6 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACO4086H1ZD | Telangana | Active | 01 Jul 2017 |
| 06AAACO4086H2ZF | Haryana | Active | 11 Jan 2022 |
| 27AAACO4086H2ZB | Maharashtra | Active | 01 Feb 2022 |
| 29AAACO4086H3Z6 | Karnataka | Active | 11 Feb 2022 |
To see the full GST registrations and return filing status of Inlife Pharma Private Limited, buy the company report.
Recent activity
Inlife Pharma Private Limited has 7 board changes on record since 2001: 4 appointments and 3 cessations. The latest: Mukta Madanmohan Agarwal was appointed as Director on 10 Dec 2018.
3 earlier events are in the company report.
Frequently asked questions
Inlife Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 September 1999 (27+ years old) and is registered under CIN U24100TG1999PTC032540.
Inlife Pharma has 4 current directors:
- Anil Kanodia - Managing Director
- Mukta Madanmohan Agarwal - Director
- Prateek Agarwal - Director
- Chetan Agarwal - Director
The latest financial statements of Inlife Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Inlife Pharma is 36AAACO4086H1ZD, registered in Telangana. The company has 10 GST registrations in all, of which 6 are active and 4 are cancelled or inactive. Other active GSTINs include 06AAACO4086H2ZF (Haryana), 27AAACO4086H2ZB (Maharashtra), 29AAACO4086H3Z6 (Karnataka).
The CIN (Corporate Identification Number) of Inlife Pharma is U24100TG1999PTC032540. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inlife Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Inlife Pharma was incorporated on 22 September 1999, making it 27+ years old. It is registered with the Registrar of Companies, Hyderabad.
Mukta Madanmohan Agarwal was appointed as Director on 10 Dec 2018. Kamini Gupta ceased to be Director on 09 May 2013. Rakesh Kumar Gupta ceased to be Director on 09 May 2013. Inlife Pharma has 7 board changes on record in total.
Yes, Inlife Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0014196).
Inlife Pharma can be reached through the website inlifehealthcare.com. Its registered office is in Hyderabad, Telangana, India.

